Ad
GERN - Geron Corporation Stock Trading
About | Geron Corporation (NASDAQ:GERN)
Not available
Quote | Geron Corporation (NASDAQ:GERN)
| Last: | $2.12 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $2.11 |
| Close: | $2.12 |
| High: | $2.15 |
| Low: | $2.09 |
| Volume: | 4,038,447 |
| Last Trade Date Time: | 09/29/2023 03:00:00 am |
News | Geron Corporation (NASDAQ:GERN)
-
2023-09-29 13:31:38 ET More on Geron Geron Corporation: The FDA, Catalysts And New Competition From Old Drugs FDA's Twist In Geron's Telomerase Tale (Rating Downgrade) Geron Corporation (GERN) Q2 2023 Earnings Call Transcript Geron rises as Goldman Sachs upgr...
-
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for imetelstat, a first-in-class investigational telomerase inhibitor, for the treatment of trans...
Message Board Posts | Geron Corporation (NASDAQ:GERN)
| Subject | By | Source | When |
|---|---|---|---|
| I can not believe these scumbags are fattening | Spike5 | investorshub | 04/27/2023 4:21:23 PM |
| I think its hilarious that just the announcement | Spike5 | investorshub | 04/25/2023 10:25:19 PM |
| The Inducement are here The Inducements are here!!! | learningcurve2020 | investorshub | 04/25/2023 4:27:46 PM |
| whytestocks: $GERN News Article - Why Shares of Geron Are Up 30% This Week | whytestocks | investorshangout | 04/20/2023 4:35:46 PM |
| Geron, CTI rally after leaked data for Legend | subslover | investorshub | 04/19/2023 6:49:15 PM |
Ad
-
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for imetelstat, a first-in-class investigational telomerase inhibitor, for the treatment of trans...
-
John A Scarlett, Chairman at Geron (NASDAQ:GERN), reported a large acquisition of company stock options on September 22, according to a new SEC fil...
-
Faye Feller, EVP at Geron (NASDAQ:GERN), reported a large acquisition of company stock options on September 22, according to a new SEC filing. What...